4.6 Letter

A noncanonical FLT3 gatekeeper mutation disrupts gilteritinib binding and confers resistance

Journal

AMERICAN JOURNAL OF HEMATOLOGY
Volume 96, Issue 7, Pages E226-E229

Publisher

WILEY
DOI: 10.1002/ajh.26174

Keywords

-

Categories

Funding

  1. American Cancer Society [MRSG-17-040-01-LIB]
  2. Drug Sensitivity and Resistance Network (DRSN) [U54CA224019]
  3. Cancer Center Support grant [5P30CA069533-22]
  4. Howard Hughes Medical Institute
  5. Leukemia & Lymphoma Society
  6. ARCS Scholar Foundation
  7. Paul & Daisy Soros Fellowship
  8. National Cancer Institute [U54CA224019, F30CA239335]
  9. Hildegard Lamfrom Physician Scientist Award
  10. American Cancer Society
  11. Cancer Early Detection Advanced Research Center

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available